Exploring novel experimental treatments for major neurodegenerative disorders  

作　　者：Xunming Ji Piotr Walczak Johannes Boltze 

机构地区：[1]Beijing Institute of Brain Disorders,Capital Medical University,Beijing,China [2]Department of Diagnostic Radiology and Nuclear Medicine,Center for Advanced Imaging Research,University of Maryland,Baltimore,Maryland,USA [3]School of Life Sciences,University of Warwick,Coventry,UK

出　　处：《Neuroprotection》2023年第2期81-83,共3页神经保护（英文）

基　　金：NIH/NIDA,Grant/Award Number:R01DA056739;Academy of Medical Sciences,Grant/Award Number:NAF\R11\1010。

摘　　要：Acute and chronic neurodegenerative disorders such as ischemic stroke or Alzheimer's disease(AD)impose a major burden on patients,their relatives,caregivers,and health care systems in general.The socioeconomic impact of neurodegenerative disorders is anticipated to escalate due to a globally ageing population and the increasing prevalence of sedentary lifestyle and inappropriate dietary habits.On the contrary.

关 键 词：Alzheimer's disease amyotrophic lateral sclerosis cell therapy CYTOPROTECTION extracellular vesicles NEURODEGENERATION STROKE 

分 类 号：R741[医药卫生—神经病学与精神病学]